CelSci (CVM)
(Delayed Data from AMEX)
$1.22 USD
+0.02 (1.67%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $1.21 -0.01 (-0.82%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for CelSci Corporation falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 1 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 1 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 31 | 36 | 36 | 30 | 21 |
Income After Depreciation & Amortization | -31 | -36 | -36 | -29 | -20 |
Non-Operating Income | 0 | 0 | 1 | 0 | 0 |
Interest Expense | 1 | 1 | 1 | 1 | 2 |
Pretax Income | -32 | -37 | -36 | -30 | -22 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -32 | -37 | -36 | -30 | -22 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -32 | -37 | -36 | -30 | -22 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -28 | -32 | -34 | -27 | -20 |
Depreciation & Amortization (Cash Flow) | 4 | 4 | 2 | 2 | 1 |
Income After Depreciation & Amortization | -31 | -36 | -36 | -29 | -20 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 44.48 | 43.15 | 40.69 | 36.76 | 31.17 |
Diluted EPS Before Non-Recurring Items | -0.73 | -0.87 | -0.93 | -0.74 | -0.69 |
Diluted Net EPS (GAAP) | -0.73 | -0.87 | -0.93 | -0.82 | -0.71 |
Fiscal Year end for CelSci Corporation falls in the month of September.
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 7.08 | 6.48 | 7.47 | 8.18 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -7.08 | -6.48 | -7.47 | -8.18 |
Non-Operating Income | NA | 0.01 | -0.03 | 0.02 | 0.00 |
Interest Expense | NA | 0.18 | 0.20 | 0.18 | 0.18 |
Pretax Income | NA | -7.24 | -6.71 | -7.63 | -8.37 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -7.24 | -6.71 | -7.63 | -8.37 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -7.24 | -6.71 | -7.63 | -8.37 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 52.01 | 48.47 | 46.96 | 44.25 |
Diluted EPS Before Non-Recurring Items | NA | -0.14 | -0.14 | -0.16 | -0.19 |
Diluted Net EPS (GAAP) | NA | -0.14 | -0.14 | -0.17 | -0.19 |